Dr. Baker's research primarily centers on understanding neurological conditions, mental health disorders, cancer treatment, and the management of pregnant women in correctional facilities. He studies Alzheimer's disease, particularly its early biomarkers, and how the brain functions in people with major depressive disorder. He also investigates how exercise can reduce cancer-related complications and improves care guidelines for patients with concurrent brain and heart diseases. Furthermore, he examines the implications of surgical outcomes in kidney cancer and explores the intersection of bacterial health and bladder cancer prognosis.
Key findings
Early biomarkers of Alzheimer's disease were detected in 484 participants, indicating changes in amyloid proteins occurred before inflammation or symptoms appeared.
In a study of 519 participants with major depressive disorder, it was found that altered brain connectivity patterns could aid in better treatment strategies.
A systematic review involving nearly 2,740 individuals showed that exercise lowered the risk of developing cancer-related lymphedema by 29%.
In kidney cancer patients with microscopic positive surgical margins, survival rates varied significantly, with a 5-year overall survival of 69% for those with positive margins compared to 79% for those without.
Research on 196 women who underwent breast cancer treatment post-augmentation found that 84% had symptoms before diagnosis, influencing management and treatment options.
Frequently asked questions
Does Dr. Baker study Alzheimer's disease?
Yes, he studies early biomarkers of Alzheimer's disease and their impact on detection and treatment.
What treatments has Dr. Baker researched?
Dr. Baker has researched various treatments including recovery plans for cancer surgeries, management of depression, and interventions for pregnant women in correctional facilities.
Is Dr. Baker's work relevant to patients with cancer?
Yes, his research includes evaluating treatment outcomes for breast cancer patients and the effects of exercise on cancer-related complications.
What does Dr. Baker's research mean for patients with depression?
His work on brain connectivity in major depressive disorder helps improve understanding and potentially lead to better treatment options.
How does Dr. Baker's work help pregnant women in correctional facilities?
His research aims to improve prenatal and postpartum care for pregnant women in jails and prisons, ensuring they receive necessary health services.
Publications in plain English
Social Determinants Are Important Barriers to Completion of the Liver Transplant Pathway and Are Associated with Waitlisting and Mortality in Hepatocellular Carcinoma.
2026
Digestive diseases and sciences
Baker B, Aridi TG, Patel M, Carter A, Singleton C +8 more
Plain English This study looked at factors that affect how patients with liver cancer (hepatocellular carcinoma, or HCC) complete the steps needed to get a liver transplant. Out of 495 patients, about 39% faced disease-related barriers and 36% faced social barriers that prevented them from completing the necessary steps. Patients with public insurance were less likely to get on the transplant list, and those living in poorer areas had a higher risk of dying.
Who this helps: This research helps patients with liver cancer and healthcare providers by highlighting barriers in the transplant process.
Improving care for incarcerated pregnant women: Policy implications for advancing maternal and child health.
2026
Nursing outlook
Baker B
Plain English This study looked at the care provided to pregnant women in U.S. jails and prisons and found that these women often do not receive the prenatal and postpartum care they need. For example, there are inconsistencies in how care is provided, with some facilities lacking proper services or policies. Improving these practices is important because it can help reduce health problems for both mothers and their babies, making care more equitable across the board.
Who this helps: This helps incarcerated women and their children.
Beyond Sterility: the Urinary Microbiome in Bladder Cancer Carcinogenesis and Treatment.
2026
Current urology reports
Aron S, Meagher M, Azari S, Baker B, Nasseri R +4 more
Plain English This research looks at the bacteria that live in the bladder and their connection to bladder cancer. It found that when the normal bacteria in the bladder are disrupted, the risk of developing cancer increases, and certain bacteria can affect how well treatments work. Understanding these relationships can lead to better, more personalized care for bladder cancer patients.
Who this helps: Patients with bladder cancer.
Ex Vivo Microfluidic Model Identifies a Role for Shear Stress during Ovarian Tumor Cell Attachment to Peritoneal Mesothelial Cells.
2026
ACS biomaterials science & engineering
Morikis VA, Baker B, Martin JA, Schab A, DiMauro A +2 more
Plain English This study looked at how ovarian cancer cells attach to the lining of the abdomen when influenced by fluid flow. Researchers developed a new device to understand this better and found that the fluid can help those cancer cells stick more effectively, with some tumor cells producing substances that improve their attachment. This is important because understanding how cancer spreads can lead to new ways to stop it from progressing.
Who this helps: This benefits patients with ovarian cancer and their doctors by providing insights for potential new treatments.
Deep Inferior Artery Perforator Flap-Enhanced Recovery After Surgery: Perspectives From Australia's Only Public Cancer-Specific Hospital.
2026
ANZ journal of surgery
Kumar R, Devine M, Charisiou D, Sinha S, Zinn R +2 more
Plain English This study from an Australian cancer hospital looked at the effects of a new recovery plan for patients undergoing breast reconstruction surgery. From 2023 to 2024, the average hospital stay dropped from about 5.8 days to 4.5 days, and the amount of pain medication needed decreased from 155 mg to 111.6 mg, while the time patients used pain control devices also fell significantly. These results highlight how a coordinated approach to patient care can improve recovery times without increasing complications.
Who this helps: Patients undergoing breast reconstruction surgery.
Plain English This study examined enzymes that require a molecule called pyridoxal 5'-phosphate (PLP) to function in the bacterium that causes tuberculosis (TB). Researchers found 45 key PLP-dependent enzymes in the TB bacteria, many of which are crucial for its survival and disease-causing ability. Understanding these enzymes could lead to better treatments for TB, especially since some of them are already targets for existing medications.
Who this helps: This research benefits patients with tuberculosis and the doctors treating them.
MTFP1 preserves β-cell cristae structure and bioenergetics to ensure insulin release and glucose homeostasis.
2026
bioRxiv : the preprint server for biology
Sarwat S, Alen R, Wu Z, Zhang C, Paszek M +8 more
Plain English This study looked at a protein called MTFP1 and its role in the cells that produce insulin in the pancreas. The researchers found that when MTFP1 was missing in these cells, insulin release in response to glucose significantly decreased, leading to glucose intolerance in mice. Specifically, there was a sharp decline in energy production and structural damage to the mitochondria, which are the cell's energy factories, hindering the cells' ability to respond properly to glucose. This matters because improving the function of MTFP1 could help develop new treatments for diabetes by enhancing insulin release and glucose control.
Who this helps: This helps patients with diabetes and their doctors.
Histology-specific Prognostic Impact of Microscopic Positive Surgical Margins in Renal Cell Carcinoma: Implications for Postoperative Surveillance.
2026
European urology open science
Musso G, Meagher MF, Dabbas M, Garofano G, Birouty N +16 more
Plain English This study looked at the impact of tiny positive surgical margins (m-PSM) on survival rates after kidney cancer surgery, specifically comparing clear-cell and non-clear-cell types of the disease. Out of nearly 8,300 patients, 307 had these positive margins, which were linked to worse survival outcomes. For clear-cell kidney cancer, patients with m-PSM had a 5-year overall survival rate of 69%, compared to 79% for those without positive margins, indicating that the presence of m-PSM can significantly affect survival.
Who this helps: This information is valuable for patients with clear-cell kidney cancer and their doctors in understanding potential outcomes after surgery.
A systematic review and meta-analysis evaluating the effect of exercise on the development of cancer-related lymphedema.
2026
JNCI cancer spectrum
Plinsinga ML, Baker B, Spence RR, Singh B, Reul-Hirche H +4 more
Plain English This study examined how exercise affects the risk of developing cancer-related lymphedema (CRL), particularly in people who have had cancer treatment. Researchers reviewed 17 studies involving nearly 2,740 people and found that those who exercised had a 29% lower risk of developing CRL compared to those who did not exercise (a relative risk of 0.71). This is significant because it suggests that engaging in any form of exercise may help reduce the risk of a common and uncomfortable side effect of cancer treatment, particularly for breast cancer survivors.
Who this helps: This helps cancer patients and survivors, especially those at risk of lymphedema.
Single-nucleus multiome analysis in the human prefrontal cortex identifies gene expression and cis-regulatory elements associated with aging.
2026
Cell reports
Catching A, Weller CA, Hu F, Bromberek S, Abbas S +15 more
Plain English This study looked at how aging affects gene activity in the human brain by analyzing samples from 357 individuals aged 15 to 100 years old. Researchers collected detailed data from over 1.5 million brain cells, identifying seven main types of brain cells and their changes related to aging. They found specific patterns in gene expression and regulatory regions linked to age, which can help us understand how the brain’s function may decline as we get older.
Who this helps: This research benefits scientists and doctors studying brain aging and related diseases.
What have we learned over the past 30 years since the discovery of the first TIR-containing plant immune receptor?
2026
Trends in plant science
Zhang D, Li Y, Zhang X, Zhong C, Baker B +2 more
Plain English This research paper looks back at 30 years of study on a key plant immune receptor called the N receptor, discovered in the 1990s. It revealed how this receptor helps tobacco plants resist the tobacco mosaic virus by detecting viral components and triggering a protective response. Understanding this immune response is important because it can help scientists develop crops that are more resistant to diseases, boosting food security.
Who this helps: This helps farmers and agricultural scientists working to improve crop resilience against diseases.
Functional Connectivity Alterations in Major Depressive Disorder.
2026
bioRxiv : the preprint server for biology
Sridhar M, Wiafe SL, Baker B, Calhoun VD
Plain English This study looked at how the brains of people with major depressive disorder (MDD) are wired differently by using brain imaging technology on 519 participants. Researchers found that people with MDD had stronger connections in some areas of the brain related to movement and emotions, but weaker connections in areas related to thinking and planning. Understanding these brain patterns helps us grasp what happens in MDD, which is important for developing better treatments.
Who this helps: This research benefits patients with depression and doctors treating them.
Abnormalities in core AD biomarkers precede inflammatory and glial markers in CSF in Autosomal Dominant Alzheimer's Disease.
2026
medRxiv : the preprint server for health sciences
Lin W, Beric A, Wisch JK, Baker B, Jerome G +39 more
Plain English This study looked at changes in proteins in the cerebrospinal fluid (CSF) of people with a specific genetic form of Alzheimer's disease (AD). Researchers analyzed samples from 484 participants and found that early signs of AD, such as changes in amyloid proteins, happened before noticeable inflammation or other symptoms occurred. They discovered that using a combination of multiple protein measurements provided better predictions of when symptoms might start than relying on single biomarkers alone.
Who this helps: This benefits patients with genetic Alzheimer's and their families by improving early detection and monitoring of the disease.
Management of brain-heart multimorbidity: a clinical practice guideline.
2026
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Edwards JD, Li Z, McFarlane P, Rabi DM, Gilbert J +54 more
Plain English This study focuses on creating guidelines for healthcare providers on how to manage patients who have both brain and heart conditions. The researchers developed 11 key recommendations, such as checking for cognitive issues in patients with atrial fibrillation and treating depression in those with coronary artery disease. These guidelines aim to improve patient care by ensuring that both brain and heart health are considered together, leading to better overall health outcomes.
Who this helps: Patients with concurrent brain and heart diseases benefit from these guidelines.
Breast Cancer After Breast Augmentation study (BCABA): A national multicentre collaborative study of patient management and outcomes.
2026
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Shah S, Manor KA, Shaker H, Harvey J, Barrett E +5 more
Plain English This study looked at how women with breast implants are diagnosed and treated for breast cancer. Researchers tracked 196 women diagnosed with breast cancer between January 2012 and January 2024, finding that most (84%) showed symptoms, while 14% were detected through routine screenings. About 72% of the cases underwent breast-conserving surgery, with 89% of those women keeping or getting a new implant, and 28.5% had a mastectomy, mostly with reconstruction. The findings are crucial because they reveal differences in treatment approaches and confirm that the complication rates are acceptable.
Who this helps: This helps patients with breast implants facing breast cancer and the doctors treating them.
Increased contributions of climate-driven wildfires to nitrogen deposition in the United States.
2026
Communications earth & environment
Campbell PC, Tong DQ, Chang S, Ma S, Li Y +5 more
Plain English A multi-decadal analysis of U.S. wildfire activity found that climate-driven wildfires have increased substantially in the western U.S., particularly in the northwest, driven by warming temperatures and drier conditions. These fires are contributing an increasing share of reactive nitrogen emissions and deposition — up to 20-40% more in the western U.S. — which can damage ecosystems by exceeding their capacity to absorb nitrogen. Smaller increases in nitrogen deposition were also found in the eastern U.S. from prescribed burns.
Radiological, Pathological, and Surgical Outcomes with Neoadjuvant Cemiplimab for Stage II-IV Cutaneous Squamous Cell Carcinoma in the Deep Sequencing in Cutaneous Squamous Cell Carcinomas (DISCERN) Trial.
2025
Cancers
Lim AM, Baker B, Lion P, Angel CM, Simmons J +12 more
Plain English This study evaluated how a treatment called neoadjuvant cemiplimab affects patients with advanced skin cancer known as cutaneous squamous cell carcinoma (CSCC) before they undergo surgery. The results showed that 73% of the 11 participants had no detectable cancer after treatment, and 91% remained cancer-free for an average of about 10 months. This matters because it suggests that cemiplimab can significantly improve outcomes for patients, potentially making surgeries less extensive and more successful.
Who this helps: Patients with advanced cutaneous squamous cell carcinoma.
Identification of GGC Repeat Expansions in ZFHX3 among Chilean Movement Disorder Patients.
2025
Movement disorders : official journal of the Movement Disorder Society
Saffie-Awad P, Moller A, Daida K, Alvarez Jerez P, Chen Z +18 more
Plain English This study looked at a group of Chilean patients with movement disorders to find genetic causes that have not been identified before. Researchers used advanced genetic sequencing and found a specific gene change (GGC repeat expansion in ZFHX3) in 4 patients, with symptoms like ataxia and issues with nerve function. The findings, which show the repeat lengths ranged from 47 to 55, suggest that longer repeats lead to earlier and more severe symptoms, and it's significant because it broadens our understanding of hereditary movement disorders beyond Europe.
Who this helps: This research benefits patients with unexplained movement disorders and their doctors by providing new diagnostic information.
Plain English This study looked at how a protein called IFIT2 helps immune cells called macrophages fight off a tuberculosis infection. Researchers found that when they increased the levels of IFIT2 in these cells, a total of 282 genes changed their activity, with 189 of those genes becoming more active. This is important because it shows how IFIT2 triggers immune responses that can better combat infections.
Who this helps: This benefits patients with tuberculosis by enhancing our understanding of immune responses, potentially leading to better treatments.
UNIK (Urologic Non-Neoplastic Investigation of Kidneys): a machine learning approach to decode benign lesion.
2025
World journal of urology
Saitta C, Garofano G, Musso G, Tanaka H, Patil D +22 more
Plain English This study focused on creating a new tool, called U.N.I.K., that uses machine learning to predict whether kidney tumors are benign before surgery. Researchers analyzed data from over 3,000 patients, finding that 7.1% had benign tumors. The machine learning model showed impressive accuracy, with XGBoost achieving a score of 0.94, meaning it does a great job at identifying which tumors don't need surgery. This is important because it can help doctors make better decisions and avoid unnecessary surgeries for patients.
Who this helps: This helps patients suspected of having kidney tumors by minimizing unnecessary surgical procedures.
No evidence of immune exhaustion after repeated SARS-CoV-2 vaccination in vulnerable and healthy populations.
2025
Nature communications
Benoit JM, Breznik JA, Wu Y, Kennedy A, Liu LM +18 more
Plain English The study looked at how repeated vaccinations for SARS-CoV-2 affect T cells, which are important for the immune response. Researchers found that after multiple vaccinations, T cell levels remained stable and did not show signs of exhaustion, meaning these cells continued to work well in responding to the virus. This is important because it shows that getting vaccinated frequently does not weaken the immune system in vulnerable groups like older adults and those on immunosuppressive drugs.
Who this helps: This benefits patients, especially vulnerable populations and those needing immunizations against COVID-19.
Positive Surgical Margins in Clear Cell Renal Cell Carcinoma: Prognostic Impact and Implications for Risk Stratification and Adjuvant Therapy.
2025
Journal of clinical medicine
Garofano G, Saitta C, Musso G, Meagher MF, Capitanio U +16 more
Plain English This study looked at the effects of positive surgical margins (PSMs)—where cancer cells are found at the edge of the tissue removed during surgery—in patients with clear cell renal cell carcinoma (ccRCC). Among over 171,000 patients, 5.9% had PSMs, and those with PSMs had a 43% higher risk of dying compared to those without, especially in later stages of cancer. This is important because understanding how PSMs affect survival can help doctors better assess patient risk and decide on follow-up treatments.
Who this helps: This helps patients with clear cell renal cell carcinoma and their doctors in making treatment decisions.
Association of Elevated Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and De Ritis Ratios With Major Complications After Surgery for Renal Cell Carcinoma: A Pathway to Optimize Charlson Comorbidity Index and Preoperative Predictive Modeling.
2025
Urology
Musso G, Birouty N, Salonia A, Garofano G, Dabbas M +16 more
Plain English This study looked at how certain blood test results—specifically the De Ritis ratio (DRR), Neutrophil-to-Lymphocyte Ratio (NLR), and Platelet-to-Lymphocyte Ratio (PLR)—can predict major complications after surgery for kidney cancer. Out of over 4,100 patients, 198 (4.8%) faced major complications like urinary leaks and bleeding. The researchers found that high levels of these blood ratios could indicate a higher risk of complications, helping doctors better assess patient risks before surgery.
Who this helps: This benefits patients undergoing kidney cancer surgery and their doctors by improving preoperative risk assessment.
The N gene protects tomato plants from tomato brown rugose fruit virus infection.
2025
Plant biotechnology journal
Zhou J, Gilliard A, Tung J, Dinesh-Kumar SP, Whitham SA +2 more
Plain English Researchers studied a special type of genetically modified tomato that carries a gene from a different plant, aimed at protecting it from a damaging virus called the tomato brown rugose fruit virus (ToBRFV). They found that this modified tomato showed strong resistance to the virus under certain temperatures (22°C), with very low virus levels detected, while regular conditions (30°C) made it less effective. This discovery is important because it offers a new way to protect tomato crops from a virus that threatens the tomato industry worldwide.
Who this helps: This benefits tomato farmers and the agricultural industry.
Haplotype-Resolved DNA Methylation at theLocus identifies Allele-Specific Epigenetic Signatures Relevant to Alzheimer's Disease Risk.
2025
bioRxiv : the preprint server for biology
Genner RM, Meredith M, Moller A, Weller C, Daida K +18 more
Plain English This study looked at how specific genetic variations in a gene related to lipid transport affect the risk of Alzheimer’s disease (AD). Researchers analyzed brain samples from 332 individuals and discovered 18 new sites where DNA methylation patterns differ based on genetic makeup, with certain variations like the ε4 allele increasing AD risk. Understanding these methylation patterns helps clarify how genetics influence AD, and could lead to better risk assessment and treatment options.
Who this helps: This research benefits patients at risk for Alzheimer's disease and their doctors.
A CGG Repeat Expansion in CSNK1E Associated with Progressive Myoclonic Epilepsy with Incomplete Penetrance.
2025
Movement disorders : official journal of the Movement Disorder Society
Akçimen F, Alvarez Jerez P, Guliyeva U, Lee J, Malik L +9 more
Plain English This study examined a family from Azerbaijan affected by progressive myoclonic epilepsy, a neurological disorder that causes seizures and muscle spasms. Researchers found a specific genetic change, a CGG repeat expansion in the CSNK1E gene, in one affected person with a repeat length of 745 and her sister who was unaffected with an even longer length of 980. This discovery matters because it shows that some genetic changes can lead to symptoms in some family members but not others, helping to improve understanding of this condition.
Who this helps: This helps patients with progressive myoclonic epilepsy and their families by providing insights into the genetic factors involved.
Pathfinder studies: a novel tool for process mapping data-driven health research to build global research capacity.
2025
BMC medical research methodology
Uppal A, Kagoro F, Monteiro-Krebs L, Bueno FTC, Marques LP +11 more
Plain English This study focused on creating a new tool called "Pathfinder" to improve health research in poorer countries, where such research is often limited. Researchers found that using this tool helps teams plan and document their research processes more effectively, aiming for better data quality and more impactful results. The Pathfinder tool allows researchers to track their progress and challenges, enhancing the overall capacity for health research where it's needed the most.
Who this helps: This benefits researchers in low-resource settings and the patients they serve.
Functional Brain Age Acceleration from Dynamic and Static Connectivity Predicts Working Memory and Attention Deficits in Schizophrenia.
2025
medRxiv : the preprint server for health sciences
Edwards-Swart SJ, Baker B, Mathalon DH, Ford JM, Preda A +5 more
Plain English This study looked at how the aging of brain function can predict attention and memory problems in people with schizophrenia. Researchers analyzed brain scans from thousands of individuals and found that factors related to both consistent brain activity and changing brain connectivity were effective in predicting issues with attention and working memory. Specifically, brain age gaps (the difference between predicted and actual age) were linked to significant declines in cognitive function, with stronger effects seen when using dynamic connectivity methods.
Who this helps: This research benefits patients with schizophrenia and their healthcare providers by improving diagnosis and treatment options.
A bio-guided investigation of Mitragyna inermis (Willd) O. Kuntze (Rubiaceae) unveils natural product isolates with potent cross-activity against sensitive and multidrug resistant Plasmodium falciparum strains in vitro.
2025
Journal of ethnopharmacology
Hassan S, Osei Bobbie S, Tchatat Tali MB, Dize D, Kamche Youbi A +5 more
Plain English This study looked at a plant called Mitragyna inermis to find new treatments for malaria, especially against strains that are resistant to current drugs. Researchers discovered that extracts from the plant were very effective, with some showing potent activity at very low concentrations (as low as 0.21 micrograms per milliliter) against different malaria strains. This research is important because it could lead to new, safer malaria treatments, especially as drug resistance continues to rise.
Who this helps: This benefits patients suffering from malaria, especially those in areas where current treatments are failing.
The Influence of Lymphovascular Invasion on T Stage Upstaging and Overall Survival in Renal Cell Carcinoma: A Population-Based Study.
2025
Clinical genitourinary cancer
Musso G, Garofano G, Dabbas M, Meagher MF, Yuen KL +10 more
Plain English This study looked at how lymphovascular invasion (LVI) affects the stage and survival rates of patients with renal cell carcinoma (RCC), a type of kidney cancer. Researchers found that among nearly 160,000 RCC patients, 11.3% had LVI, which was linked to larger tumors and a worse prognosis; specifically, those with LVI had a 5-year survival rate of 61% compared to 85% for those without it. Understanding the presence of LVI can help doctors better assess patient risk and adjust care plans, particularly for those with early-stage tumors.
Who this helps: This helps patients with kidney cancer and their doctors by providing clearer information on prognosis and treatment options.
Long-read sequencing of single cell-derived melanoma subclones reveals divergent and parallel genomic and epigenomic evolutionary trajectories.
2025
bioRxiv : the preprint server for biology
Liu Y, Goretsky A, Keskus AG, Malikic S, Ahmad T +24 more
Plain English This study examined how different subtypes of melanoma cells evolve over time by using a method that looks at their genetic changes in detail. They analyzed 23 subtypes from a mouse model and discovered that some changes in their genes and DNA patterns happened independently across different groups, indicating that cancer cells can evolve in similar ways. Understanding these patterns is important because it can help in the development of more targeted treatment strategies for melanoma.
Who this helps: This helps researchers and doctors working with melanoma patients.
Clinical Interchangeability of PD-L1 Immunohistochemistry Assays in First-Line Non-Small Cell Lung Cancer Management With Cemiplimab.
2025
JCO precision oncology
Perez J, Kerr KM, Baker B, Fang F, Li J +11 more
Plain English This research studied two tests that measure a protein called PD-L1, important for determining how to treat advanced non-small cell lung cancer (NSCLC). The study found that these two tests, known as 22C3 and SP263, generally produced consistent results—showing an 88% agreement rate—allowing doctors to confidently use either test to decide on treatment options. Importantly, patients treated with cemiplimab showed significantly longer survival compared to those receiving chemotherapy.
Who this helps: This benefits patients with advanced non-small cell lung cancer, as it simplifies the testing process and treatment decisions.
Rising Trends of Aggressive Renal Cell Carcinoma Among Younger Adults: Insights From the National Cancer Database.
2025
Clinical genitourinary cancer
Garofano G, Saitta C, Musso G, Meagher MF, Capitanio U +17 more
Plain English This study looked at kidney cancer trends in younger adults aged 20-39 from 2004 to 2021. Researchers found that 27.45% of the 30,849 cases were classified as aggressive, with cases increasing by 3.53% each year. The study also revealed that Black and Asian/Pacific Islander patients were more likely to have aggressive forms of the disease, and survival rates at 10 years were much lower for aggressive cases (65%) compared to non-aggressive cases (91.7%).
Who this helps: This helps doctors understand risk factors for aggressive kidney cancer in younger patients.
COMPLEX-VALUED PHASE SYNCHRONY REVEALS DIRECTIONAL COUPLING IN FMRI AND TRACKS MEDICATION EFFECTS.
2025
ArXiv
Wiafe SL, Soleimani N, Seraji M, Baker B, Miller R +2 more
Plain English This study looked at a new method that can track how different parts of the brain communicate and how that changes with medication. Researchers found that their method, called complex-valued phase synchrony (CVPS), was better at capturing these interactions than older methods, particularly when measuring the effects of antipsychotic medications on brain activity. For example, the study was able to show specific brain communication patterns, like how signals flow from the back of the brain to the front, which are connected to how medications work in the brain.
Who this helps: This helps patients taking antipsychotic medications by improving understanding of their effects on brain function.
Manful EE, Adu-Amankwaah F, Madhvi A, Bubb K, Pietersen RD +1 more
Plain English This research reviewed the role of a protein called IFIT2 in fighting infections, cancer, and various diseases. It found that IFIT2 is important not just for its antiviral properties but also for its potential to act against several types of cancer, improve responses to bacterial and fungal infections, and help in autoimmune and neurological diseases. Understanding IFIT2 better can lead to new diagnostic tools and treatments, making it valuable for managing conditions like cancer, lupus, and Alzheimer's disease.
Who this helps: Patients suffering from infections, cancers, and autoimmune diseases.
Care of the Dying Patient: Maximizing Compassionate Care on the Battlefield.
2025
Military medicine
Muir KB, Edwards J, Dindinger R, Ingram B, Baker B
Plain English This study looks at how to provide better end-of-life care for soldiers on the battlefield, especially during large-scale combat when many may be injured and resources are limited. It highlights that during such situations, military medical providers may have to manage many dying patients with very little support, similar to what was observed in Ukraine. By using principles from civilian palliative care, healthcare workers can reduce suffering and make more compassionate decisions about how to care for seriously injured soldiers.
Who this helps: This benefits military medical personnel and the soldiers who are injured in combat.
Soft-Tissue Chest Wall Reconstruction for Secondary Angiosarcoma: Systematic Review and Case Series.
2025
Annals of plastic surgery
Hamilton S, Fuzzard S, Stone C, Webb A, Baker B +4 more
Plain English This study focused on a rare type of cancer called secondary angiosarcoma, which can develop in the chest area after patients receive radiation treatment for breast cancer. The researchers looked at 30 cases from a specialized center and reviewed 31 other articles with over 300 cases. They found various techniques used for reconstructing the chest wall after surgery, and they proposed a new system to help doctors decide on the best reconstruction approach for their patients.
Who this helps: This benefits patients recovering from secondary angiosarcoma and their doctors by providing clearer guidance on treatment options.
Dynamic Brain Age Modeling Identifies Network-Specific Cognitive Deficits in Schizophrenia.
2025
Research square
Sendi M, Edwards-Swart S, Baker B, Mathalon D, Ford J +5 more
Plain English Researchers studied how brain function relates to attention and memory problems in people with schizophrenia by developing models of brain age using brain scans. They found that a larger difference between predicted brain age and actual age (called brain age gap or BAG) was linked to worse attention and memory performance. Specifically, they discovered that the dynamic measures of brain connectivity were more closely tied to cognitive issues than static measures, meaning that understanding brain activity over time can help identify problems better.
Who this helps: Patients with schizophrenia and their healthcare providers.
A Rare Case of Uterine Rupture in the First Trimester of Pregnancy Secondary to Placenta Accreta Spectrum.
2025
Clinical case reports
Huertas Ayala C, Fazal H, Winkler M, Baker B
Plain English This study looked at a rare and serious condition called uterine rupture during the early months of pregnancy, which can happen when the placenta grows too deeply into the uterine wall. It highlights the importance of quickly identifying a condition known as placenta accreta spectrum to ensure proper treatment and reduce the risk of death for the mother. Recognizing this issue early on can make a significant difference in care.
Who this helps: This helps pregnant women and their healthcare providers.
Apple cider vinegar for prevention of urinary lithiasis (APUL): a randomized crossover trial.
2025
International urology and nephrology
Baker B, Herforth C, Low J, Craig R, Christman M
Plain English This study looked at whether apple cider vinegar (ACV) can help prevent kidney stones by increasing certain substances in urine. Researchers found that while ACV did not change anything in the urine, coconut water increased urinary citrate by about 273.8 mg over 24 hours, and lemon water increased it by about 167.7 mg. This is important because higher citrate levels can help reduce the risk of kidney stones.
Who this helps: This benefits patients at risk for kidney stones.
Molecular links between tuberculosis and lung cancer: pathogenesis and therapeutic challenges.
2025
Archives of microbiology
Adu-Amankwaah F, Buabeng SD, Agyekum IS, Tshililo N, Baatjies L +1 more
Plain English This study examined the connection between tuberculosis (TB) and lung cancer, finding that TB increases the risk of lung cancer, and vice versa, due to both diseases causing chronic inflammation and other harmful changes in the lungs. The overlap of biological processes makes diagnosing and treating patients more complicated since both conditions can weaken the immune system and affect each other’s treatment. This research is important because understanding how these two diseases interact can lead to better diagnostic methods and treatment plans, especially in areas where both are common.
Who this helps: Patients suffering from tuberculosis and lung cancer.
2025 White Paper on Recent Issues in Bioanalysis: Biomarkers Calibrators & Stability; Evaluation of NULISA; Neurofilament & Autoantibody Biomarker Assays; Removing IgM Interference; ELISpot & FluoroSpot Best Practices; Modular HD Cytometry; Single-cell Analysis Imaging Cytometry (PART 2A - Recommendations on Biomarkers Discovery, Development, Validation & Regulatory Approval, Ligand-Binding Assays (LBA) and Cell-Based Assays (CBA) PART 2B - Regulatory Agencies' Input on Biomarkers, IVD/CDx and Biomarker Assay Validation (BAV)).
2025
Bioanalysis
Hersey S, McGuire K, Kholmanskikh O, Bivi N, Bandukwala A +72 more
Plain English This paper summarizes discussions from a recent workshop where over 1,200 bioanalysis professionals gathered to focus on current issues related to measuring biomarkers and validating tests for new therapies and vaccines. The attendees made a series of recommendations aimed at improving testing quality and compliance with regulations to ensure better health outcomes. The importance of this work lies in its potential to enhance the reliability of new diagnostic tests and treatments, benefitting the overall healthcare system.
Who this helps: Patients and healthcare providers benefit from these improved diagnostic tools and therapies.
Improved electrode stimulation stability of Utah arrays.
2025
Bioelectronic medicine
Stump T, Baker B, Caldwell R, Sharma R, Negi S +1 more
Plain English This study looked at a type of electrode called the Utah electrode array (UEA), which helps people with sensory loss and other issues. Researchers tested a new coating for the electrodes and found that 50% of those with the standard coating failed after a specific test, while the new coating had no failures even after similar stress tests. This improvement is important because it means these electrodes could last longer and work better, making a difference in the lives of people who rely on them.
Who this helps: Patients with sensory loss, spinal cord injuries, and limb loss.
Long-read sequencing identifiesrepeat expansions in Parkinson's disease.
2025
medRxiv : the preprint server for health sciences
Akçimen F, Daida K, Lange LM, Moller A, Miano-Burkhardt A +22 more
Plain English This study examined the role of specific genetic changes, called GAA repeat expansions, in people with Parkinson's disease (PD). Researchers analyzed DNA from 411 individuals with PD and found these genetic changes in five patients, indicating a potential new cause of the disease. This is significant because it can help identify new ways to understand and treat PD.
Who this helps: This helps patients with Parkinson's disease and their doctors by providing insights into potential genetic factors.
Long-read sequencing identifies FGF14 repeat expansions in Parkinson's disease.
2025
Brain : a journal of neurology
Akçimen F, Daida K, Lange LM, Moller A, Miano-Burkhardt A +22 more
Plain English This study explored the role of a genetic change called FGF14 repeat expansions in causing Parkinson's disease. Researchers examined 411 people with Parkinson's and found that five of them had these expansions, which had not been previously linked to the disease. This discovery expands our understanding of genetic factors in Parkinson's and highlights how advanced DNA sequencing can help identify rare causes of the condition.
Who this helps: Patients with Parkinson's and their doctors.
Laksh Malik Kimberley J Billingsley Cornelis Blauwendraat Giacomo Musso Kensuke Daida Andrew B Singleton Margaret F Meagher Mai Dabbas Giuseppe Garofano Natalie Birouty
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.